Press Releases
NBE-Therapeutics Announces Successful Validation of its SMAC™-Technology for the...
Basel, Switzerland, February 21, 2014 - NBE-Therapeutics (“NBE”) today announced that it has presented the successful validation of its enzymatic SMAC™-Technology for the generation of...
Press Releases
Domain Therapeutics enters into collaboration with XOMA
DTect-All(TM) platform will be used to screen for GPCR-directed allosteric modulator antibodies Strasbourg, France, February 4, 2014 – Domain Therapeutics, a biopharmaceutical company specializing in...
Press Releases
Cellectis grants genOway an exclusive sublicense for its homologous...
The agreement covers the creation and sale of rodent animal models, the sale of existing rodent animal models and sublicensing rightsParis, France, February 4, 2014...
Press Releases
TxCell to present an innovative, personalized cell-based immunotherapy approach...
TxCell SA, a clinical stage biotechnology company developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, announces today...
Press Releases
DARA BioSciences enters into pharmacy supply deal with RainTree
US-based pharmaceutical firm dedicated to the commercialization of oncology treatment and oncology supportive care products DARA BioSciences has signed a pharmacy supply...
Press Releases
Curie-Cancer and Servier continue a renewed partnership in cancer...
Their joint aim is to identify new therapeutic targets in ‘triple negative’ breast cancers Paris and Suresnes, France, January 28, 2014 – Curie-Cancer, the body...
Press Releases
Clasado and University of Oxford demonstrate effect of prebiotics...
Study results provide positive data for ongoing human trials Reading and Oxford, UK, January 23, 2014 – Clasado, the manufacturers and suppliers of the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.